SEGMENT REPORTING (Details - Business unit segment and consolidated results) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Revenue from External Customer [Line Items]
Total revenues	$ 18,305	$ 15,750	$ 32,805	$ 27,714
Total cost of revenues	5,084	2,620	9,736	5,291
Gross profit	$ 13,221	$ 13,130	$ 23,069	$ 22,423
Gross margin	72.00%	83.00%	70.00%	81.00%
Software
Revenue from External Customer [Line Items]
Total revenues	$ 11,614	$ 10,487	$ 19,203	$ 16,561
Total cost of revenues	1,348	843	2,339	1,728
Gross profit	$ 10,266	$ 9,644	$ 16,864	$ 14,833
Gross margin	88.00%	92.00%	88.00%	90.00%
Software | Immunetrics
Revenue from External Customer [Line Items]
Service offerings			$ 400
Services
Revenue from External Customer [Line Items]
Total revenues	$ 6,691	$ 5,263	13,602	$ 11,153
Total cost of revenues	3,736	1,777	7,397	3,563
Gross profit	$ 2,955	$ 3,486	$ 6,205	$ 7,590
Gross margin	44.00%	66.00%	46.00%	68.00%
Reorganization of internal structure	$ 1,300		$ 1,900
Service offerings			1,300
Services | Immunetrics
Revenue from External Customer [Line Items]
Total revenues			1,100
Service offerings	$ 400		$ 700
Revenue Benchmark | Product Concentration Risk
Revenue from External Customer [Line Items]
Concentration percentage	100.00%	100.00%	100.00%	100.00%
Revenue Benchmark | Product Concentration Risk | Software
Revenue from External Customer [Line Items]
Concentration percentage	63.00%	67.00%	59.00%	60.00%
Revenue Benchmark | Product Concentration Risk | Services
Revenue from External Customer [Line Items]
Concentration percentage	37.00%	33.00%	41.00%	40.00%